Auxilium On a Roll ...
Health Care: Drugs
Aradigm Corporation (ARDM: OTC)
$0.14 0.00 | 0.00%
06/04/12 - 11:25 AM ET
866.00 / 134.80K
Vol / Avg. Vol:0.14 / 0.14
Open / Prev. Close:0.14 - 0.14
Today's Range:0.09 - 0.22
52 Wk Range:28.57%
Performance YTD:TheStreet Rating:
Portfolios with ARDM
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- UserCreditCard 2
- UserSpazZiggyCurrent
- Userflaherty1
Latest ARDM Headlines from TheStreet
- Insiders Trading TJX, NSPH, ARDM, APOL 07.12.11 | 10:07 am
- MannKind's Work Is Never Done 07.15.05 | 11:07 am
- Exubera-nce in the Insulin Market 06.10.05 | 07:06 am
- Pressure Builds in PIPEs 12.14.04 | 03:12 pm
- Health Stocks in Motion 09.29.04 | 04:09 pm
- Drug Delay Has Inhale Gasping and a Rival Catching Up 07.17.01 | 06:07 pm
Press Releases for ARDM
- Aradigm Announces Fourth Quarter 2011 And Full Year Financial Results - Business Wire 03.27.12 | 07:03 am
- Aradigm Receives U.S. FDA Clearance For Phase 3 Clinical Trial Of Pulmaquin™ In Patients With Non-Cystic Fibrosis Bronchiectasis - Business Wire 03.12.12 | 07:03 am
- US Patent Protection For Pulmaquin™ Is Extended With Issuance Of A Composition Of Matter Patent - Business Wire 02.21.12 | 07:02 am
- Aradigm To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2012 On February 13 - Business Wire 02.08.12 | 07:02 am
- Aradigm To Present At Biotech Showcase 2012 On January 9 - Business Wire 01.05.12 | 01:01 pm
- Aradigm Selects Pulmaquin™ For Phase 3 Development And Announces Issuance Of Its First U.S. Patent Covering Inhaled Ciprofloxacin Formulations - Business Wire 12.07.11 | 07:12 am
- Aradigm Announces Third Quarter 2011 Financial Results - Business Wire 11.10.11 | 07:11 am
- Aradigm To Present At The 10th Annual BIO Investor Forum On October 26 - Business Wire 10.20.11 | 07:10 am
- Aradigm Presents Additional Analyses Of The Clinical Results From ORBIT-1 And ORBIT-2 Trials Of Inhaled Ciprofloxacin At The 2011 European Respiratory Society (ERS) Annual Congress - Business Wire 09.21.11 | 07:09 am
- Aradigm To Present At Rodman & Renshaw Annual Global Investment Conference - Business Wire 09.07.11 | 07:09 am
Partner Headlines for ARDM
- MannKind in Jeopardy - Analyst Blog - Zacks 01.20.11 | 10:01 am
